Hutchison China Meditech Ltd. Share Price

Hutchison China Meditech Ltd. competes in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry. It is headquartered in , Hong Kong and is traded on the London Stock Exchange, through the symbol HCM-LN.

Previous Close:
GBX£2.31 0.0022% (February 19th, 2024)

Latest Share Trading Activity for Hutchison China Meditech Ltd.

Day Open:
GBX£225.90(previous open GBX£2.23)
Day High:
GBX£228.00(previous high GBX£2.23)
Day Low:
GBX£225.90(previous low GBX£2.23)

About Hutchison China Meditech Ltd.

Company Description
chi-med (nasdaq/aim: hcm) is an innovative biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. it has a portfolio of nine cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of china. note: our linkedin posts may contain forward-looking statements about our business. forward-looking statements involve risks and uncertainties which may cause our actual results to be materially different. we do not undertake to update our forward-looking statements. please refer to chi-med’s filings with the u.s. securities and exchange commission and on aim for more information.
Chief Executive Officer (CEO)
Christian Hogg
Postal Address
Hong Kong
Phone Number

Hutchison China Meditech Ltd. Historic Prices and Volume

Issue CountryGB
52 Week Range£0.00 - £3.38
52 Week Change-£0.18
50 Day Moving Average£2.33
200 Day Moving Average£2.63
Average 10 Day Volume37847
Average 30 Day Volume70794
5 Day % Change4%
30 Day % Change4%
3 Month % Change-22%
6 Month % Change13%
1 Year % Change-18%
2 Year % Change-41%
5 Year % Change-94%
Year To Date % Change-19%

© 2024

While does what we can to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.